{"title":"다음 뉴스 ─ 전체기사 ─ IT","url":"https://news.daum.net/breakingnews/digital","favicon":"https://news.daum.net/breakingnews/favicon.ico","elements":[{"title":"셀트리온 천식치료제 ‘CT-P39’ 유럽 품목허가 신청","contents":"파이낸셜뉴스<span class=\"txt_bar\"> · </span><span class=\"info_time\">18:16</span>","link":"https://v.daum.net/v/20230425181615263","retrieved":1682414191025},{"title":"\"안질환 치료제 ‘SB15’ 오리지널과 효과 유사\"","contents":"파이낸셜뉴스<span class=\"txt_bar\"> · </span><span class=\"info_time\">18:16</span>","link":"https://v.daum.net/v/20230425181603251","retrieved":1682414191025},{"title":"[김나인의 樂樂한 콘텐츠] `피의 게임2` 앞세워 생존게임… 웨이브 `사냥할 것인가, 당할 것인가`","contents":"디지털타임스<span class=\"txt_bar\"> · </span><span class=\"info_time\">18:15</span>","link":"https://v.daum.net/v/20230425181540246","retrieved":1682414191025},{"title":"'가상자산법' 국회 정무위 법안소위 통과","contents":"지디넷코리아<span class=\"txt_bar\"> · </span><span class=\"info_time\">18:13</span>","link":"https://v.daum.net/v/20230425181325177","retrieved":1682414191026},{"title":"식약처, 동아제약 '챔프시럽' 강제 회수…\"품질 부적합\"","contents":"한국경제<span class=\"txt_bar\"> · </span><span class=\"info_time\">18:13</span>","link":"https://v.daum.net/v/20230425181301162","retrieved":1682414191036},{"title":"KT IPTV '지니 TV', 2023 iF 디자인 어워드 본상 수상","contents":"데일리안<span class=\"txt_bar\"> · </span><span class=\"info_time\">18:13</span>","link":"https://v.daum.net/v/20230425181301160","retrieved":1682414191036},{"title":"넷마블에프앤씨, 대한항공과 파트너십 MOU","contents":"이데일리<span class=\"txt_bar\"> · </span><span class=\"info_time\">18:12</span>","link":"https://v.daum.net/v/20230425181248153","retrieved":1682414191037},{"title":"NHN클라우드, 3년 연속 핀테크 중소기업 클라우드 지원","contents":"서울경제<span class=\"txt_bar\"> · </span><span class=\"info_time\">18:12</span>","link":"https://v.daum.net/v/20230425181214135","retrieved":1682414191037},{"title":"웨이브 \"넷플릭스 韓 3.3조 투자 환영…중요한 것은 임팩트\"","contents":"뉴스1<span class=\"txt_bar\"> · </span><span class=\"info_time\">18:10</span>","link":"https://v.daum.net/v/20230425181050078","retrieved":1682414191038},{"title":"간호법 거부권 가닥 잡았나…표결 이틀 앞두고 처우 개선책 발표(종합)","contents":"조선비즈<span class=\"txt_bar\"> · </span><span class=\"info_time\">18:10</span>","link":"https://v.daum.net/v/20230425181031067","retrieved":1682414191045},{"title":"'OOOGPT' 이제 못쓰나…오픈AI, 상표권 행사 시작","contents":"이데일리<span class=\"txt_bar\"> · </span><span class=\"info_time\">18:08</span>","link":"https://v.daum.net/v/20230425180833989","retrieved":1682414191046},{"title":"국내 '톱10' 제약사 R&D 총액, 로슈의 13%","contents":"한국경제<span class=\"txt_bar\"> · </span><span class=\"info_time\">18:08</span>","link":"https://v.daum.net/v/20230425180804978","retrieved":1682414191048},{"title":"[팩플] 네이버웹툰 김준구 “애플·아마존 안 두려워…우린 선두”","contents":"중앙일보<span class=\"txt_bar\"> · </span><span class=\"info_time\">18:06</span>","link":"https://v.daum.net/v/20230425180659949","retrieved":1682414191049},{"title":"\"내년 美서 AI 플랫폼 신약 임상\"","contents":"한국경제<span class=\"txt_bar\"> · </span><span class=\"info_time\">18:06</span>","link":"https://v.daum.net/v/20230425180603914","retrieved":1682414191050},{"title":"프리시젼바이오, 글로벌 동물진단 '빅4' 중 2곳 뚫어","contents":"한국경제<span class=\"txt_bar\"> · </span><span class=\"info_time\">18:05</span>","link":"https://v.daum.net/v/20230425180506886","retrieved":1682414191051}]}